Bupivacaine Protein Binding in Pre-Eclampsia

Coyle, Dennis E.; Elconin, H.; Denson, Donald D.; Santos, Divina J.

doi:10.1097/00000542-198509001-00448

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Accordingly, the free concentration of local anaesthetics is better correlated with toxic symptoms than is the total plasma concentration (1 7, 18). Parturients sufrering from preeclampsia/eclampsia were excluded from the study because of their altered plasma levels of a-1 -acid glycoprotein ( 19).…”

Section: Discussionmentioning

confidence: 99%

Plasma protein binding of bupivacaine in pregnant women at term

Wulf

Münstedt

Maier

1991

Acta Anaesthesiol Scand

View full text Add to dashboard Cite

The increased toxicity of bupivacaine in parturients is a well-known phenomenon. The reduced plasma protein binding of bupivacaine is one of the possible reasons. Therefore, we measured the free fraction of bupivacaine in plasma samples of parturients and non-pregnant volunteers. The free fraction was significantly higher in parturients (8.2% vs 5.4%) associated with a lower concentration of the alpha-1-acid glycoprotein (0.42 vs 1.01 g/l) and a higher concentration of progesterone (156 vs 0.4 ng/ml). The addition of progesterone to plasma samples of non-pregnant volunteers did not influence the free fraction of bupivacaine, whereas the addition of alpha-1-acid glycoprotein to the plasma of parturients decreased the free fraction significantly. Therefore, the lower concentration of this protein is the principal reason for the higher free fraction of bupivacaine in pregnancy and possibly one of the causes of the higher incidence of toxic side effects of bupivacaine in obstetric use.

show abstract

Section: Discussionmentioning

confidence: 99%